Prevention of Acute Mountain Sickness by Intermittent Hypoxia

Sponsor
Heidelberg University (Other)
Overall Status
Completed
CT.gov ID
NCT00559832
Collaborator
(none)
75
1
2
16
4.7

Study Details

Study Description

Brief Summary

Acclimatization by mountaineering prior to high altitude sojourns have shown to be effective in prevention of acute mountain sickness (AMS).

The aim of this study is to investigate whether intermittent exposure to normobaric hypoxia during sleep is also effective to prevent AMS.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypoxic Exposure
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
75 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
Prevention of Acute Mountain Sickness by Sleeping at Simulated Altitude (Normobaric Hypoxia)
Study Start Date :
Mar 1, 2006
Actual Study Completion Date :
Jul 1, 2007

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Normoxia

Sleeping in normoxia for 14 nights prior to one night at 4500 m

Experimental: Hypoxia

Sleeping in normobaric hypoxia for 14 nights at altitudes from 2500 - 3300 m prior to one night at 4500 m

Other: Hypoxic Exposure
Sleeping in normobaric hypoxia for 14 nights at altitudes from 2500 - 3300 m prior to one night at 4500 m

Outcome Measures

Primary Outcome Measures

  1. incidence of acute mountain sickness [during one night at 4500 m]

Secondary Outcome Measures

  1. Sleep quality [during one night at altitude]

  2. ventilatory acclimatization [during one night at altitude]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy
Exclusion Criteria:
  • Altitude exposure above 2000 m 8 weeks prior or during the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sports Medicine, University Hospital Heidelberg Germany 69120

Sponsors and Collaborators

  • Heidelberg University

Investigators

  • Principal Investigator: Christoph Dehnert, MD, University Hospital Heidelberg

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00559832
Other Study ID Numbers:
  • 039/2006
First Posted:
Nov 16, 2007
Last Update Posted:
Nov 16, 2007
Last Verified:
Nov 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 16, 2007